AI-generated summary
The authors randomized 75 patients with fibromyalgia to gallium-arsenide laser, placebo laser, or low-dose amitriptyline and assessed pain, tender points, fatigue, depression and quality of life. They report that both laser and amitriptyline therapy were associated with improvements in clinical symptoms and quality of life, with laser showing greater benefit for pain and fatigue.
- Participants
- 75
- Who or what was studied
- Patients with fibromyalgia
- Limits stated in the abstract
- The abstract describes a single-blind design with a placebo arm, but does not report wavelength, and it does not state details beyond a single-blind trial of one clinical center.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Fibromyalgia, Depression, Dose, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.